comparemela.com
Home
Live Updates
HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate : comparemela.com
HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Related Keywords
Guangzhou
,
Guangdong
,
China
,
Sweden
,
Australia
,
Stockholm
,
Sydney
,
New South Wales
,
Switzerland
,
Singapore
,
Swiss
,
Martina Ribar Hestericov
,
Dirk Oehlers
,
Jeetendra Vaghjiani
,
Jane Lowe
,
Bryce Carmine
,
Head Of External Communications
,
Lonza Group Ltd
,
European Hematology Association
,
Swiss Exchange
,
Haemalogix Ltd Contact Details
,
Ir Department
,
Haemalogix Ltd
,
Singapore Exchange Securities Trading Limited
,
Clinical Development Strategic Marketing
,
Prnewswire Haemalogix Ltd Haemalogi
,
Logix Ltd
,
Executive Director
,
Clinical Development
,
Strategic Marketing
,
Swiss Alps
,
Scientific Advisory Board
,
Multiple Myeloma
,
External Communications
,
Group Ltd
,
Sequential Cohort Study Comparing Kappamab Alone
,
Low Dose Dexamethasone
,
Technology
,
Health
,
Business
,
Europe
,
Biotechnology
,
Pr Newswire
,
comparemela.com © 2020. All Rights Reserved.